WhatsApp
betapramestiasia

Big Pharma’s Next Efficiency Play: Halving Chromatography Buffers Without Touching Yield

  • beta-pramesti-asia
  • industry-pharmaceutical
  • process-chromatography

Big Pharma’s Next Efficiency Play: Halving Chromatography Buffers Without Touching Yield

Biologics makers are drowning in water and buffers. New gradient designs, column strategies, and buffer‑recycling loops show they can slash volumes by tens of percent — with documented step‑level cuts of 50% and even 90% in specific scenarios.

Industry: Pharmaceutical | Process: Chromatography

Here’s the uncomfortable math of biologics: producing 1 gram of a typical molecule can take about 65 liters of water just to prepare buffers, according to GEN. In standard monoclonal antibody (mAb) downstream processing (DSP), total water consumption runs roughly 3,000–7,000 kg per kg of product, with capture and polishing chromatography consuming more than 50% of that water, per BioProcess Online.

The kicker: water makes up about 95% of all inputs in downstream processing, GEN notes. Every liter of buffer prepared must be managed, treated, or disposed — a point underscored by BioProcess Online. That explains why a wave of quiet, practical changes to chromatography — from “smart” gradients to column regeneration and buffer recycling — is suddenly moving from nice‑to‑have to standard operating procedure.

Column scaling and UHPLC methods

Method miniaturization is the bluntest tool available. Swapping a conventional 25 cm × 4.6 mm column for a 10 cm × 2.1 mm column can save about 90% of solvent (i.e., buffer) volume for the same separation, as Technology Networks details. At matched linear velocity, a 2.1 mm internal diameter (ID) column uses roughly one‑tenth the volume of a 4.6 mm column, with comparable efficiency using sub‑2 µm particles (very small stationary phase beads that increase efficiency), per Technology Networks and LCGC. Peak heights often climb too — on the order of 5–20× — further boosting sensitivity (LCGC).

In biopharma purification, even preparative ion exchange (IEX; binding and elution based on charge) or affinity columns are available in smaller bed formats or multi‑column continuous setups (multiple columns rotating through load, wash, elute, re‑equilibrate), directly lowering buffer demand.

Gradient design and dwell volume

Gradient elution (changing the mobile phase composition over time) is a buffer lever when timed precisely. Steepening or compressing gradient segments can shrink elution time and the re‑equilibration hold. In one worked example, scaling adjustments cut re‑equilibration from 5 minutes to about 2 minutes, according to LCGC. Matching column volume and pump dwell volume (system’s pre‑column mixing volume) when changing column size further reduces unproductive flow; net‑net, careful gradient optimization can shave tens of percent off re‑equilibration buffer without sacrificing resolution.

Eliminating 3 minutes of re‑equilibration at 1 mL/min saves 3 mL per injection, and on some methods that can approach about 60–70% of total cycle buffer, per LCGC.

Other method‑level tweaks

Beyond gradients and column ID, the small things add up: shorter injections and stopping flow when idle reduce cycle volume; multicolumn continuous operation eliminates idle re‑equilibration altogether; and isocratic maps that blend buffers cut waste. On the device side, “mobile phase recycling” systems can capture and return clean solvent to the reservoir; reports indicate about 50% cuts in solvent use, LCGC notes. Shorter columns and smaller particles proportionally trim run time and buffer volume as well (Technology Networks; LCGC).

Devices that capture and filter the outgoing mobile phase (solvent recyclers) routinely cut consumption by half or more, per LCGC; in practice, sterile capture can pair with pharma‑grade filtration hardware such as 316L stainless steel cartridge housings to maintain cleanliness during reuse.

Column regeneration and cleaning‑in‑place (CIP)

Regeneration is a hidden buffer sink. Columns typically require CIP (cleaning‑in‑place; in‑situ caustic/salt washes) using about 5–10 column volumes (CV; the internal bed volume) of cleaning buffer per cycle. Strategies to minimize that load include recycling cleaning solutions, combining CIP across columns, and optimizing flow. For example, performing simultaneous CIP on two columns enables “buffer recycling without an intermediate hold flask” — a scheduling trick that can deliver about 30–50% savings in CIP buffer use, according to BioProcess Online.

Even simply reducing CIP flow rates or using static holds instead of continuous high flow can trim cleaning buffer consumption by roughly 20–50% per column batch (BioProcess Online).

Selective reuse of regeneration buffers

Not every stream is a recycling candidate. Wash buffers rich in impurities (cell debris, unbound protein) may be unsuitable to recycle due to re‑contamination risk, per BioProcess Online. In contrast, buffers used after CIP (re‑equilibration) or CIP solutions themselves can be reused because impurities have already been removed by the cleaning step. Collecting spent equilibrium buffer after elution and CIP can reclaim about 5 CV that would otherwise be flushed.

In a Protein A capture step (affinity capture of antibodies), simply recycling equilibration buffer cut equilibration buffer demand by about 50% — more than 10% of total Protein A buffer usage — with no loss of yield or purity, according to a Lund University analysis on SSRN. Recovered CIP caustic, after neutralization and quality checks, could be routed upstream to polishing steps to further reduce fresh cleaning volumes (as discussed in BioProcess Online).

Buffer recycling and in‑line reuse

The clearest play is closed‑loop reuse. Lund researchers demonstrated batch‑to‑batch and continuous multicolumn schemes for recycling Protein A equilibration buffer: buffer effluent was collected, pH‑adjusted, and returned to the pool — halving fresh buffer for that step and delivering about 10% total downstream buffer savings from a single equilibration recycle, with no observable change in antibody yield or purity (SSRN). pH adjustment can be executed precisely with a dosing pump to hit spec before the buffer returns to service.

Beyond Protein A, polishing steps that use simple salts or pH buffers can be conditioned — for instance, sterile‑filtered and adjusted — and fed back, provided quality controls prevent impurity carryover (BioProcess Online). In practice, that may include sterile filtration trains using cartridge filters to maintain clarity ahead of reuse. General HPLC practice points the same way: solvent‑recycling devices that capture and filter the outgoing mobile phase routinely cut consumption by half or more (LCGC).

Quantitative impact and operating trends

Even without explicit recycling, moving to continuous/closed‑system DSP has “enhanced productivity and reduced buffer consumption” through tighter scheduling, a review notes (BioProcess Online). Stack that with smaller columns, faster gradients, and reuse schemes, and the savings compound.

Consider the levers together: reducing column ID by about 2× can deliver roughly 5–10× lower buffer volumes (LCGC; Technology Networks). Eliminating 3 minutes of re‑equilibration at 1 mL/min saves 3 mL per injection and can remove on the order of about 60–70% of total cycle buffer on certain methods (LCGC). In the Lund study, a single equilibration recycle produced about a 10% reduction in total downstream buffer usage (SSRN). Full implementations that add CIP and polishing reuse plausibly cut buffer volumes by tens of percent — a large absolute saving for plants moving thousands of liters daily.

The financial case is direct. Analyses cite multi‑million‑dollar savings from modest water/buffer cuts. One pharmaceutical plant’s water‑recovery initiative projected a 10% water‑use reduction worth about $3 million over 10 years (Xylem). In Indonesia and elsewhere, tighter effluent rules (e.g., Indonesia’s Permen 5/2014 wastewater standards) make lower discharge volumes directly translate to lower treatment cost and compliance risk.

What a reduced‑buffer future looks like

The takeaway is practical: combine method‑level changes (miniaturized columns; UHPLC) with process innovations (multi‑column sequencing; in‑line buffer recycling), and water/buffer use in chromatography can be significantly reduced. Documented results range from about 50% savings in individual buffer steps (SSRN) to about 90% solvent (buffer) cuts by hardware scaling (Technology Networks).

Facilities that build reuse loops also need standard conditioning: sterile filtration, pH adjustment, and quality checks. Those controls map to familiar unit operations, from pharma‑grade stainless cartridge housings to precise chemical dosing — the kinds of infrastructure that help buffer recycling deliver sustainability gains and throughput improvements simultaneously (BioProcess Online; LCGC).